Skip to main content
. 2021 May 20;8:612506. doi: 10.3389/fmed.2021.612506

Table 1.

Clinical characteristics of the study population along with mean DEXA osteo-metabolic parameters.

Overall, N = 40 Alendronate, N = 25 Denosumab, N = 15 p
Age, Mean (SD) 82.1 (5.8) 81.4 (6.3) 83.3 (4.8) 0.315
Female, N (%) 35 (87.5) 22 (88.0) 13 (86.7) 0.999
Hip fracture type 16 (40.0) 12 (48.0) 4 (26.7) 0.317
BMI, Median (IQR) 22.7 (20.5, 25.6) 23.4 (20.6, 27.9) 21.0 (19.4, 23.6) 0.069
Hand Grip, Median (IQR)
Females 15.70 (10.85, 17.75) 15.75 (11.10, 17.47) 15.00 (10.00, 17.80) 0.785
Males 22.50 (22.10, 24.30) 22.50 (19.70, 24.70) 23.20 (22.65, 23.75) 0.999
Barthel, Median (IQR) 90 (75, 100) 90 (70, 95) 95 (85, 100) 0.143
ADL, Median (IQR) 6 (5, 6) 6 (6, 6) 6 (5, 6) 0.247
IADL, Median (IQR) 7.0 (3.8, 8.0) 7.0 (5.0, 8.0) 7.0 (1.5, 8.0) 0.597
MNA-SF, Median (IQR) 12 (9, 13) 12 (10, 13) 12 (9, 12.5) 0.357
CIRS comorbidity, Median (IQR) 4.0 (2.8, 5.2) 4.0 (2.0, 5.0) 4.0 (3.5, 5.5) 0.977
CIRS severity, Median (IQR) 1.8 (1.6, 2.1) 1.8 (1.5, 2.1) 1.9 (1.7, 2.1) 0.769
N. of drugs, Median (IQR) 5.0 (3.0, 7.0) 5.0 (2.0, 7.0) 5.0 (4.5, 8.0) 0.338
<5 15 (37.5) 11 (44.0) 4 (26.7) 0.367
5–7 16 (40.0) 10 (40.0) 6 (40.0)
8 or more 9 (22.5) 4 (16.0) 5 (33.3)
SPMSQ Median (IQR) 1.0 (0.0, 3.0) 1.0 (0.0, 3.0) 2.0 (0.0, 3.0) 0.954
VIT.D 25-OH (ng/ml), Median (IQR) 15.60 (7.53, 25.45) 15.40 (6.20, 22.00) 21.40 (9.45, 26.60) 0.295
PTH (ng/L) Median (IQR) 33.50 (25.00, 50.50) 33.00 (25.00, 48.00) 35.00 (26.50, 51.50) 0.557
FN-BMD, Median (IQR) 0.65 (0.62, 0.73) 0.66 (0.63, 0.72) 0.63 (0.59, 0.73) 0.395
TH-BMD, Median (IQR) 0.72 (0.65, 0.77) 0.72 (0.65, 0.77) 0.72 (0.63, 0.78) 0.893
LS-BMD, Median (IQR) 0.96 (0.87, 1.07) 0.97 (0.88, 1.14) 0.91 (0.82, 1.03) 0.235
TBS, Median (IQR) 1.09 (0.96, 1.18) 1.07 (0.92, 1.13) 1.15 (1.06, 1.23) 0.050
RSMI kg/m2, Median (IQR) 5.90 (5.12, 6.86) 6.22 (5.18, 7.02) 5.76 (5.08, 6.60) 0.299

BMI, body mass index; FN, Femoral neck; LS, Lumbar spine; TH, Total hip; ADL, activities of daily living; IADL, instrumental activities of daily living; CIRS, cumulative illness rating scale; MNA-SF, Mini nutritional assessment; SPMQS, short portable mental status questionnaire; PHT, parathormone; BMD, Bone marrow density; TBS, Trabecular bone score; RSMI, Relative skeletal muscle index.